{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:42:10Z","timestamp":1790480530222,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>\n            Certain classes of antihypertensive drug may exert specific, blood pressure (BP)-independent protective effects on end-organ damages such as left ventricular hypertrophy, although the overall evidence has not been definitive in clinical trials. To unravel antihypertensive drug-induced gene expression changes that are potentially related to the amelioration of end-organ damages, we performed in vivo phenotypic evaluation and transcriptomic analysis on the heart and the kidney, with administration of antihypertensive drugs to two inbred strains (ie, hypertensive and normotensive) of rats. We chose 6 antihypertensive classes: enalapril (angiotensin-converting enzyme inhibitor), candesartan (angiotensin receptor blocker), hydrochlorothiazide (diuretics), amlodipine (calcium-channel blocker), carvedilol (vasodilating \u03b2-blocker), and hydralazine. In the tested rat strains, 4 of 6 drugs, including 2 renin-angiotensin system inhibitors, were effective for BP lowering, whereas the remaining 2 drugs were not. Besides BP lowering, there appeared to be some interdrug heterogeneity in phenotypic changes, such as suppressed body weight gain and body weight-adjusted heart weight reduction. For the transcriptomic response, a considerable number of genes showed prominent mRNA expression changes either in a BP-dependent or BP-independent manner with substantial diversity between the target organs. Noticeable changes of mRNA expression were induced particularly by renin-angiotensin system blockade, for example, for genes in the natriuretic peptide system (\n            <jats:italic>Nppb<\/jats:italic>\n            and\n            <jats:italic>Corin<\/jats:italic>\n            ) in the heart and for those in the renin-angiotensin system\/kallikrein-kinin system (\n            <jats:italic>Ren<\/jats:italic>\n            and rat\n            <jats:italic>Klk1<\/jats:italic>\n            paralogs) and those related to calcium ion binding (\n            <jats:italic>Calb1<\/jats:italic>\n            and\n            <jats:italic>Slc8a1<\/jats:italic>\n            ) in the kidney. The research resources constructed here will help corroborate occasionally inconclusive evidence in clinical settings.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.121.18026","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T10:00:34Z","timestamp":1639044034000},"page":"413-423","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Transcriptomic Response in the Heart and Kidney to Different Types of Antihypertensive Drug Administration"],"prefix":"10.1161","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3185-5661","authenticated-orcid":true,"given":"Fumihiko","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Department of Gene Diagnostics and Therapeutics (F.T., Y.-Q.L., M.I., M.Y.A., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."},{"name":"Medical Genomics Center (F.T., K.M., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qiang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Gene Diagnostics and Therapeutics (F.T., Y.-Q.L., M.I., M.Y.A., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Isono","sequence":"additional","affiliation":[{"name":"Department of Gene Diagnostics and Therapeutics (F.T., Y.-Q.L., M.I., M.Y.A., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2709-6754","authenticated-orcid":true,"given":"Mia Yang","family":"Ang","sequence":"additional","affiliation":[{"name":"Department of Gene Diagnostics and Therapeutics (F.T., Y.-Q.L., M.I., M.Y.A., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."},{"name":"Department of Clinical Genome Informatics, Graduate School of Medicine, The University of Tokyo, Japan (M.Y.A., N.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Mori","sequence":"additional","affiliation":[{"name":"Medical Genomics Center (F.T., K.M., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-8415","authenticated-orcid":true,"given":"Norihiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gene Diagnostics and Therapeutics (F.T., Y.-Q.L., M.I., M.Y.A., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."},{"name":"Medical Genomics Center (F.T., K.M., N.K.), Research Institute, National Center for Global Health and Medicine, Japan."},{"name":"Department of Clinical Genome Informatics, Graduate School of Medicine, The University of Tokyo, Japan (M.Y.A., N.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.03.019"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008170.pub3"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0777-3"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.136655"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-4-200308190-00006"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.10.011"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.048090"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.1963"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz401"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002284"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2001.013"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.89.5.2204"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2007.07.021"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2016.00018"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0155-8"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-017-0659-5"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1369\/0022155419849386"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071568"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.18-073"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2017.11.005"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00693.2017"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.6"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009096.pub2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118162"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15504"},{"key":"e_1_3_2_27_2","first-page":"5","article-title":"Regulation of renal calbindin-D28K.","volume":"87","author":"Hemmingsen C","year":"2000","unstructured":"Hemmingsen, C. Regulation of renal calbindin-D28K. Pharmacol Toxicol. 2000;87(suppl 3):5\u201330.","journal-title":"Pharmacol Toxicol"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10686"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000028979.98877.0c"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.12.111"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1139\/y05-001"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.121.18026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:23:19Z","timestamp":1715595799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.121.18026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.121.18026"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.121.18026","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"2021-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}